Dr. Lori Muffly, MD
Claim this profileStanford Cancer Institute
Studies T-Lymphoblastic Leukemia/Lymphoma
Studies Acute Lymphoblastic Leukemia
11 reported clinical trials
17 drugs studied
Area of expertise
1T-Lymphoblastic Leukemia/Lymphoma
CD19 positive
CD33 positive
Stage IV
2Acute Lymphoblastic Leukemia
CD19 positive
CD22 negative
CD19 negative
Affiliated Hospitals
Clinical Trials Lori Muffly, MD is currently running
Axicabtagene Ciloleucel
for Non-Hodgkin Lymphoma
This is a phase Ib study to establish safety of Axi-Cel-2 in patients with Large B Cell Lymphoma (LBCL) who are at high risk of relapse.
Recruiting1 award Phase 1
CAR T-Cell Therapy
for Leukemia
This trial is testing a treatment that uses special immune cells from a donor, modified to target and kill cancer cells, in adults with a specific type of blood cancer. These cells act like guided missiles, finding and destroying cancer cells by recognizing specific markers.
Recruiting1 award Phase 1
More about Lori Muffly, MD
Clinical Trial Related2 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Lori Muffly, MD has experience with
- Cyclophosphamide
- CD22 CAR
- Fludarabine
- Brexucabtagene Autoleucel
- Dasatinib
- CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells
Breakdown of trials Lori Muffly, MD has run
T-Lymphoblastic Leukemia/Lymphoma
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lori Muffly, MD specialize in?
Lori Muffly, MD focuses on T-Lymphoblastic Leukemia/Lymphoma and Acute Lymphoblastic Leukemia. In particular, much of their work with T-Lymphoblastic Leukemia/Lymphoma has involved CD19 positive patients, or patients who are CD33 positive.
Is Lori Muffly, MD currently recruiting for clinical trials?
Yes, Lori Muffly, MD is currently recruiting for 4 clinical trials in Stanford California. If you're interested in participating, you should apply.
Are there any treatments that Lori Muffly, MD has studied deeply?
Yes, Lori Muffly, MD has studied treatments such as Cyclophosphamide, CD22 CAR, Fludarabine.
What is the best way to schedule an appointment with Lori Muffly, MD?
Apply for one of the trials that Lori Muffly, MD is conducting.
What is the office address of Lori Muffly, MD?
The office of Lori Muffly, MD is located at: Stanford Cancer Institute, Stanford, California 94305 United States. This is the address for their practice at the Stanford Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.